"European stocks have got off to a positive start to the week helped by a decent performance in Asia, as well as renewed optimism over progress on a possible vaccine after AstraZeneca resumed its UK trials after last week's suspension over safety concerns, and possible side effects", said Michael Hewson, chief market analyst at CMC Markets UK.
The search for vaccine has further brought together the Swedish-British biopharma major AstraZeneca and the University of Oxford.
Oxford University confirmed the resumption and said: "In large trials such as this, it is expected that some participants will become unwell and every case must be carefully evaluated to ensure careful assessment of safety".
Dr Chiu will work with Imperial's Professor Robin Shattock and Oxford's Professor Sarah Gilbert to assess the vaccines by delivering them to a small group of healthy volunteers as an aerosol - similar to how inhaled asthma medications are delivered.
The human trials resumed days after a pause had been announced in the trials after an adverse reaction in one of the participants.
The UK committee concluded its investigations and recommended to the MHRA that trials in the UK are safe to restart.
Odoemena said Russia's action also poses a potential health risk, adding that already following Russia's "misstep" is China, which has made a decision to approve Sinovac's COVID-19 vaccine candidate. The company, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV) in Pune, is leading the effort to develop India's first indigenous Covid-19 vaccine, named "Covaxin".
Carson City School District: Three additional confirmed cases of COVID-19
Many secondary teachers are still in the dark about what they are teaching this fall, and if they are to be in a school or online. Students attending Special Education Congregated Sites, as well as other support programs, will begin on Tuesday, September 15.
"This new agreement could help us vaccinate millions of people across the country, as well as help create a United Kingdom vaccine manufacturing facility to speed up access to a potential Covid-19 candidate and boost the country's resilience against future pandemics", said Britain's Business Secretary Alok Sharma.
In comparison, Oxford's vaccine uses a harmless virus - a chimpanzee cold virus, engineered so it can't spread - to carry the coronavirus' spike protein into the body, which should trigger an immune response.
The offices of British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca PLC in Macclesfield, England, July 21, 2020. It says it will consult with relevant organizations as to when to restart the trials.
It is not known if the disease is directly related to the AstraZeneca vaccine, the NYT said.
In Britain, infection rates are again surging in line with the rising trend seen of late in the rest of Europe, forcing the government to tighten public restrictions from Monday and impose local lockdowns.
"It's really one of the safety valves that you have on clinical trials such as this", he told "CBS This Morning".